DOSIERANLAGE
European patent · EP4017648 · In force
Register entry
- Publication number
- EP4017648
- Application number
- EP20753940
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 10, 2020
- Published
- Jun 29, 2022
- Granted
- Sep 2, 2026
- Protection ends at the latest
- Aug 9, 2040
- Next annual fee due
- Aug 31, 2027
- IPC classes
- B05C 11/10 (2006.01)B05C 5/02 (2006.01)
- Priority
- DE 102019212373 19.08.2019
- PCT application
- PCT/EP2020/072394 10.08.2020
- PCT publication
- WO2021/032521 25.02.2021
- Filing language
- German
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 17, 2026
Agent entered
- Representative
- BOVARD AG, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 17.09.2026
- Sep 2, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 02.09.2026
Parties
Inventor
HAAG, Gerd
78655 Dunningen, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.